Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Neutropenia and FMO3[original query] |
---|
Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib. Investigational new drugs 2011 Oct 29 (5): 953-62. Steeghs Neeltje, Mathijssen Ron H J, Wessels Judith A M, de Graan Anne-Joy, van der Straaten Tahar, Mariani Mariangela, Laffranchi Bernard, Comis Silvia, de Jonge Maja J A, Gelderblom Hans, Guchelaar Henk-J |
Pharmacogenomics variation in drug metabolizing enzymes and transporters in relation to docetaxel toxicity in Lebanese breast cancer patients: paving the way for OMICs in low and middle income countries. Omics : a journal of integrative biology 2013 Jul 17 (7): 353-67. Awada Zainab, Haider Syed, Tfayli Arafat, Bazarbachi Ali, El-Saghir Nagi S, Salem Ziad, Shamseddine Ali, Taher Ali, Zgheib Nathalie Khouei |
Predictive Value of FMO3 Variants on Plasma Disposition and Adverse Reactions of Oral Voriconazole in Febrile Neutropenia. Pharmacology 2020 9 106 (3-4): 202-210. Wang Xiaokang, Zhao Jingjing, Wen Ting, Liao Xueyi, Luo B |
- Page last reviewed:Feb 1, 2024
- Content source: